September 14, 2019
A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
Read More
January 30, 2019
A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue Sarcoma
Read More
January 30, 2019
Phase 1 Study of CK-301 as a Single Agent in Subjects With Advanced Cancers
Read More
January 30, 2019
Phase 1 Study of CK-301 as a Single Agent in Subjects With Advanced Cancers
Read More
January 30, 2019
A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC)
Read More
January 30, 2019
Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer
Read More
January 30, 2019
Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer
Read More
January 30, 2019
Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer
Read More
January 30, 2019
Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma
Read More
January 30, 2019
BAY43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma
Read More
January 30, 2019
A Study of Tivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell Carcinoma
Read More
January 30, 2019
Axitinib in Metastatic Renal Cell Carcinoma Patients With Favorable Prognostic Factors
Read More
Load More
X